Antibiotic | Drug content (µg/ tablet) | Bacteriostatic diameter/mm | Susceptibility | Criteria for drug susceptibility tests /mm | ||
---|---|---|---|---|---|---|
R | I | S | ||||
CZ | 30 | 21 | S | ≤ 14 | 15 ~ 17 | ≥ 18 |
CN | 30 | 18 | I | ≤ 13 | 14 ~ 20 | ≥ 21 |
AMP | 10 | 0 | R | ≤ 13 | 14 ~ 16 | ≥ 17 |
AMK | 30 | 22 | S | ≤ 14 | 15 ~ 16 | ≥ 17 |
CTR | 30 | 30 | S | ≤ 14 | 15 ~ 17 | ≥ 18 |
CXM | 30 | 21 | S | ≤ 14 | 15 ~ 17 | ≥ 18 |
SXT | 25 | 14 | I | ≤ 10 | 11 ~ 15 | ≥ 16 |
PB | 300(IU) | 14 | S | ≤ 8 | 9 ~ 11 | ≥ 12 |
CHL | 30 | 7 | R | ≤ 12 | 13 ~ 17 | ≥ 18 |
CC | 2 | 0 | R | ≤ 14 | 15 ~ 20 | ≥ 21 |
IPM | 10 | 30 | S | ≤ 13 | 14 ~ 15 | ≥ 16 |
FFC | 30 | 0 | R | ≤ 15 | 16 ~ 20 | ≥ 21 |
LEV | 5 | 28 | S | ≤ 13 | 14 ~ 16 | ≥ 17 |
DO | 30 | 10 | R | ≤ 10 | 11 ~ 13 | ≥ 14 |
AZI | 15 | 8 | R | ≤ 13 | 14 ~ 17 | ≥ 18 |
KAN | 30 | 22 | S | ≤ 13 | 14 ~ 17 | ≥ 18 |
GEN | 10 | 20 | S | ≤ 12 | 13 ~ 14 | ≥ 15 |
PEN | 10(U) | 7 | R | ≤ 13 | 14 ~ 16 | ≥ 17 |
CIP | 5 | 26 | S | ≤ 15 | 16 ~ 20 | ≥ 21 |
ERY | 15 | 7 | R | ≤ 13 | 14 ~ 22 | ≥ 23 |
MY | 2 | 0 | R | ≤ 14 | 15 ~ 20 | ≥ 21 |
VAN | 30 | 0 | R | ≤ 15 | 16 ~ 20 | ≥ 21 |
STR | 10 | 17 | S | ≤ 11 | 12 ~ 14 | ≥ 15 |
MI | 30 | 16 | I | ≤ 14 | 15 ~ 18 | ≥ 19 |